Article

Open Innovation: Transforming the Model of Biopharmaceutical R&D

Don Frail, Vice President, AstraZeneca Innovative Medicines Group discusses the company's approach to innovation and the upcoming session at the BIO International Convention

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
August 9th 2025

Next for Biopharma: Speed, Strategy, and Smarter Systems

Mike Hennessy Jr.
Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?
August 9th 2025

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
August 9th 2025

Polpharma Biologics, Fresenius Kabi Enter Licensing Agreement for Proposed Biosimilar to Takeda’s Entyvio

Feliza Mirasol
Site Logo
August 9th 2025

Vaccines and Virus Purification through the Ages

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 9th 2025

Roche Divulges New Alzheimer’s Disease Research Data at AAIC 2025

Feliza Mirasol
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 9th 2025

New Cancer Research and Treatment Center in Development in London

Susan Haigney
© 2025 MJH Life Sciences

All rights reserved.